| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.31 | 0.06 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.07 |